ETON moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend. In 25 of 29 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 86%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ETON as a result. In 75 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 10-day moving average for ETON crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for ETON entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ETON's RSI Indicator exited the oversold zone, 19 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where ETON advanced for three days, in 245 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
ETON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ETON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (30.691) is normal, around the industry mean (10.407). P/E Ratio (108.739) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (15.798) is also within normal values, averaging (178.797).
SIGA saw its Momentum Indicator move below the 0 level on October 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In 74 of the 87 cases, the stock moved further down in the following days. The odds of a decline are at 85%.
The Moving Average Convergence Divergence Histogram (MACD) for SIGA turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 39 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
SIGA moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for SIGA crossed bullishly above the 50-day moving average on September 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIGA advanced for three days, in 234 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 138 of 175 cases where SIGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.356) is normal, around the industry mean (11.138). P/E Ratio (-104.000) is within average values for comparable stocks, (-7.600). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.152). SIGA's Dividend Yield (0.769) is considerably higher than the industry average of (0.038). P/S Ratio (4.161) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. SIGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
ETON | SIGA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 91 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 89 Overvalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 9 | 100 | |
SMR RATING 1..100 | 28 | 91 | |
PRICE GROWTH RATING 1..100 | 35 | 63 | |
P/E GROWTH RATING 1..100 | 19 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ETON (89) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than ETON’s over the last 12 months.
ETON's Profit vs Risk Rating (9) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that ETON’s stock grew significantly faster than SIGA’s over the last 12 months.
ETON's SMR Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for SIGA (91) in the Pharmaceuticals Other industry. This means that ETON’s stock grew somewhat faster than SIGA’s over the last 12 months.
ETON's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as SIGA (63) in the Pharmaceuticals Other industry. This means that ETON’s stock grew similarly to SIGA’s over the last 12 months.
ETON's P/E Growth Rating (19) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that ETON’s stock grew significantly faster than SIGA’s over the last 12 months.
| ETON | SIGA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | N/A |
| Stochastic ODDS (%) | 1 day ago 82% | 2 days ago 75% |
| Momentum ODDS (%) | 1 day ago 77% | 2 days ago 85% |
| MACD ODDS (%) | N/A | 2 days ago 81% |
| TrendWeek ODDS (%) | 1 day ago 79% | 2 days ago 79% |
| TrendMonth ODDS (%) | 1 day ago 80% | 2 days ago 80% |
| Advances ODDS (%) | 11 days ago 84% | 8 days ago 80% |
| Declines ODDS (%) | 4 days ago 79% | 4 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 72% | 2 days ago 72% |
| Aroon ODDS (%) | 1 day ago 83% | 2 days ago 79% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ETON’s FA Score shows that 3 FA rating(s) are green while SIGA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ETON’s TA Score shows that 4 TA indicator(s) are bullish while SIGA’s TA Score has 5 bullish TA indicator(s).
ETON (@Pharmaceuticals: Generic) experienced а -6.77% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was +0.65% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
ETON is expected to report earnings on Nov 05, 2026.
SIGA is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.
| Ticker / NAME | Correlation To ETON | 1D Price Change % | ||
|---|---|---|---|---|
| ETON | 100% | +1.46% | ||
| MDGL - ETON | 34% Loosely correlated | -1.01% | ||
| VKTX - ETON | 31% Poorly correlated | -2.08% | ||
| SIGA - ETON | 30% Poorly correlated | +0.96% | ||
| ARRY - ETON | 30% Poorly correlated | -3.23% | ||
| FDMT - ETON | 29% Poorly correlated | -6.10% | ||
More | ||||
A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.
| Ticker / NAME | Correlation To SIGA | 1D Price Change % | ||
|---|---|---|---|---|
| SIGA | 100% | -0.95% | ||
| EBS - SIGA | 33% Poorly correlated | -1.43% | ||
| ETON - SIGA | 29% Poorly correlated | -1.77% | ||
| AYTU - SIGA | 28% Poorly correlated | -2.49% | ||
| AMRX - SIGA | 27% Poorly correlated | +1.81% | ||
| SBFM - SIGA | 25% Poorly correlated | -2.09% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GQQQ | 35.82 | 0.28 | +0.80% |
| Astoria US Quality Growth Kings ETF (GQQQ) | |||
| VWOB | 63.50 | 0.06 | +0.09% |
| Vanguard Emerging Markets Government Bond ETF (VWOB) | |||
| FDRS | 23.94 | N/A | N/A |
| Founder-Led ETF | |||
| CALI | 50.02 | -0.01 | -0.01% |
| iShares Short-Term California Muni Active ETF (CALI) | |||
| TMFS | 33.56 | -0.05 | -0.14% |
| Motley Fool Small-Cap Growth ETF (TMFS) | |||